CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 60 enrolled
Drug / intervention
Passiflora incarnata +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01665170
NCT01665170Phase 3Completed

A Randomized, Double Blind, Placebo-controlled Pilot Study on the Efficacy of Passiflora Incarnata L. in an Acute Stressful Situation

Pascoe Pharmazeutische Praeparate GmbH·interventional·Posted Aug 15, 2012·Updated Dec 9, 2015

In Brief

A Phase 3 clinical trial evaluating Passiflora incarnata and Placebo for Healthy and Stress. Completed, enrolled 60 participants across 1 site.

Detailed Summary

A randomized, double blind, placebo-controlled pilot study on the efficacy of Passiflora incarnata L. in an acute stressful situation

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Stress
CountriesGermany
CollaboratorsDaacro

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 15, 2012
Enrollment StartMay 1, 2012
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 13.9 years ago

Interventions

Passiflora incarnatadrug

3 x 1 tablet per day for 3 days

Placebodrug

3 x 1 ablet per day for 3 days